Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160680
Status:
COMPLETED
Last Update Posted:
2023-08-31
First Post:
2005-09-08
Brief Title:
ATAREAL Antihistamine Treatment for Allergic Rhinitis in Real Life
Sponsor:
UCB SA - Pharma Sector
Organization:
UCB Pharma
Study Overview
Official Title:
A Pilot Open Monocenter Randomized Two Parallel Groups Clinical Efficacy Trial Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets Once a Day in Adults Suffering From Persistent Allergic Rhinitis PER Over 6 Months
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparison of clinical efficacy and safety of levocetirizine in PER continuous versus on demand measured by evolution of individual symptom scores during 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-003858-26 | EUDRACT_NUMBER | None | None |